Cyclic AMP signaling in pancreatic islets

Advances in Experimental Medicine and Biology

Volumn 654, Issue , 2010, Pages 281-304

  Furman, Brian ^a   Ong, Wee Kiat ^b   Pyne, Nigel J ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b NONE

Author keywords

Adenylyl cyclase; Cyclic AMP; Epac; GLP 1; Insulin secretion; Phosphodiesterase; Protein kinase A

Indexed keywords

ADENYLATE CYCLASE; ADRENALIN; CALCIUM ION; CYCLIC ADENOSINE DIPHOSPHATE RIBOSE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INSULIN; ISOPRENALINE; NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE; OXYNTOMODULIN; POTASSIUM CHANNEL; PROTEIN KINASE C; SOMATOSTATIN; UNCLASSIFIED DRUG; VOLTAGE SENSITIVE CALCIUM CHANNEL; VOLTAGE SENSITIVE POTASSIUM CHANNEL; CALCIUM; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAPGEF3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL COMPARTMENTALIZATION; CELL DESTRUCTION; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CELL SYNCHRONIZATION; CELL TYPE; EARLY RESPONSE GENE; ELECTRIC ACTIVITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXOCYTOSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HORMONE RELEASE; HORMONE SYNTHESIS; INSULIN RELEASE; INSULIN SYNTHESIS; MOLECULAR DYNAMICS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; HUMAN; METABOLISM; MOUSE; PATHOLOGY; REVIEW; SECRETION;

ANIMALS; APOPTOSIS; CALCIUM; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXOCYTOSIS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICE; MODELS, BIOLOGICAL; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 77953957372     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-90-481-3271-3_13     Document Type: Article

References (172)

1. Turtle J, Kipnis D. An adrenergic receptor mechanism for the control of cyclic 3'5' adenosine monophosphate synthesis in tissues. Biochem Biophys Res Commun 1967;28:797-802.
2. Charles M, Fanska R, Schmid F, Forsham P, Grodsky G. Adenosine 3',5'-monophosphate in pancreatic islets: glucose-induced insulin release. Science 1973;179:569-571.
3. Grill V, Cerasi E. Activation by glucose of adenyl cyclase in pancreatic islets of the rat. FEBS Lett 1973;33:311-4.
4. Kim J, Roberts C, Berg S, Caicedo A, Roper S, Chaudhari N. Imaging cyclic AMP changes in pancreatic islets of transgenic reporter mice. PLoS ONE 2008;3:e2127.
5. Landa LJ, Harbeck M, Kaihara K, Chepurny O, Kitiphongspattana K, Graf O, Nikolaev V, Lohse M, Holz G, Roe M. Interplay of Ca2+ and cAMP signaling in the insulin-secreting MIN6 beta-cell line. J Biol Chem 2005;280:31294-302. (Pubitemid 41291867)
6. Ramos L, Zippin J, Kamenetsky M, Buck J, Levin L. Glucose and GLP-1 stimulate cAMP production via distinct adenylyl cyclases in INS-1E insulinoma cells. J Gen Physiol 2008;132:329-38.
7. Sharp G. The adenylate cyclase-cyclic AMP system in islets of Langerhans and its role in the control of insulin release. Diabetologia 1979;16:287-96. (Pubitemid 9200505)
8. Persaud S, Jones P, Howell S. Glucose-stimulated insulin secretion is not dependent on activation of protein kinase A. Biochem Biophys Res Commun 1990;173:833-9.
9. Lester L, Langeberg L, Scott J. Anchoring of protein kinase A facilitates hormone-mediated insulin secretion. Proc Natl Acad Sci U S A 1997;94:14942-7. (Pubitemid 28041479)
10. Holz G, Habener J. Signal transduction crosstalk in the endocrine system: pancreatic betacells and the glucose competence concept. Trends Biochem Sci 1992;17:388-93.
11. Howell S, Jones P, Persaud S. Regulation of insulin secretion: the role of second messengers. Diabetologia 1994;37 Suppl 2:S30-5. (Pubitemid 24288789)
12. Braun M, Ramracheya R, Johnson P, Rorsman P. Exocytotic properties of human pancreatic beta-cells. Ann N Y Acad Sci 2009;1152:187-93.
13. MacIntosh C, Horowitz M, Verhagen M, Smout A, Wishart J, Morris H, Goble E, Morley J, Chapman I. Effect of small intestinal nutrient infusion on appetite, gastrointestinal hormone release, and gastric myoelectrical activity in young and older men. Am J Gastroenterol 2001;96:997-1007. (Pubitemid 32319128)
14. Brubaker P, Anini Y. Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol 2003;81:1005-12. (Pubitemid 38045829)
15. Feinle C, Chapman I, Wishart J, Horowitz M. Plasma glucagon-like peptide-1 (GLP- 1) responses to duodenal fat and glucose infusions in lean and obese men. Peptides 2002;23:1491-95. (Pubitemid 35223018)
16. Wolfe M, Zhao K, Glazier K, Jarboe L, Tseng C. Regulation of glucose-dependent insulinotropic polypeptide release by protein in the rat. Am J Physiol Gastrointest Liver Physiol 2000;279:G561-6.
17. Thorens B. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci U S A 1992;89:8641-5.
18. Preitner F, Ibberson M, Franklin I, Binnert C, Pende M, Gjinovci A, Hansotia T, Drucker D,Wollheim C, Burcelin R, Thorens B. Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest 2004;113:635-45. (Pubitemid 38542513)
19. Selbie L, Hill S. G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptorsignalling pathways. Trends Pharmacol Sci 1998;19:87-93. (Pubitemid 28197809)
20. Yamazaki S, Katada T, Ui M. Alpha 2-adrenergic inhibition of insulin secretion via interference with cyclic AMP generation in rat pancreatic islets. Mol Pharmacol 1982;21:648-53. (Pubitemid 12128279)
21. 2 inhibition of insulin secretion in HIT cells. Diabetes 1987;36:1047-53.
22. Morgan D, Kulkarni R, Hurley J,Wang Z,Wang R, GhateiM, Karlsen A, Bloom S, Smith D. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells. Diabetologia 1998;41:1482-91. (Pubitemid 28551620)
23. Kimple M, Nixon A, Kelly P, Bailey C, Young K, Fields T, Casey P. A role for Gz in pancreatic islet β-cell biology. J Biol Chem 2005;280:31708-13. (Pubitemid 41291918)
24. Drucker D, Philippe J, Mojsov S, Chick W, Habener J. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci U S A 1987;84:3434-8. (Pubitemid 17085418)
25. Doyle M, Egan J. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther 2007;113:546-93. (Pubitemid 46365961)
26. Maida A, Lovshin J, Baggio L, Drucker D. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice. Endocrinology 2008;149:5670-8.
27. Sonoda N, Imamura T, Yoshizaki T, Babendure J, Lu J, Olefsky J. Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells. Proc Natl Acad Sci U S A 2008;105:6614-9. (Pubitemid 351754555)
28. Amiranoff B, Vauclin-Jacques N, Laburthe M. Functional GIP receptors in a hamster pancreatic beta cell line, In 111: specific binding and biological effects. Biochem Biophys Res Commun 1984;123:671-6. (Pubitemid 14010142)
29. Siegel E, Creutzfeldt W. Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content. Diabetologia 1985;28:857-61. (Pubitemid 16176057)
30. Wheeler M, Gelling R, McIntosh C, Georgiou J, Brown J, Pederson R. Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties. Endocrinology 1995;136:4629-9.
31. Zhou J, Livak M, Bernier M, Muller D, Carlson O, Elahi D, Maudsley S, Egan J. Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets. Am J Physiol Endocrinol Metab 2007;293:E538-47. (Pubitemid 47205098)
32. Yada T, Sakurada M, Ihida K, Nakata M, Murata F, Arimura A, Kikuchi M. Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J Biol Chem 1994;269:1290-3. (Pubitemid 24032521)
33. Ahrén B. Role of pituitary adenylate cyclase-activating polypeptide in the pancreatic endocrine system. Ann N Y Acad Sci. 2008;1144:28-35.
34. Borboni P, Porzio O, Pierucci D, Cicconi S, Magnaterra R, Federici M, Sesti G, Lauro D, D'Agata V, Cavallaro S, Marlier L. Molecular and functional characterization of pituitary adenylate cyclase-activating polypeptide (PACAP-38)/vasoactive intestinal polypeptide receptors in pancreatic beta-cells and effects of PACAP-38 on components of the insulin secretory system. Endocrinology 1999;140:5530-7. (Pubitemid 30645340)
35. Yamada S, Komatsu M, Sato Y, Yamauchi K, Kojima I, Aizawa T, Hashizume K. Timedependent stimulation of insulin exocytosis by 3',5'-cyclic adenosine monophosphate in the rat islet beta-cell. Endocrinology 2002;143:4203-9. (Pubitemid 35239549)
36. Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, Matsumoto S, Kamohara M, Hiyama H, Yoshida S, Momose K, Ueda Y, Matsushime H, Kobori M, Furuichi K. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 2005;326:744-51. (Pubitemid 39655983)
37. Overton H, Babbs A, Doel S, Fyfe M, Gardner L, Griffin G, Jackson H, Procter M, Rasamison C, Tang-Christensen M, Widdowson P, Williams G, Reynet C. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 2006;3:167-75.
38. Chu Z, Jones R, He H, Carroll C, Gutierrez V, Lucman A, Moloney M, Gao H, Mondala H, Bagnol D, Unett D, Liang Y, Demarest K, Semple G, Behan D, Leonard J. A role for betacell- expressed G protein-coupled receptor 119 in glycemic control by enhancing glucosedependent insulin release. Endocrinology 2007;148:2601-9. (Pubitemid 46984798)
39. Hanoune J, Defer N. Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol 2001;Toxicol.;41:145-74. (Pubitemid 32385886)
40. 2+ regulation of adenylyl cyclases in cAMP microdomains. Physiol Rev 2007;87:965-1010. (Pubitemid 47084674)
41. Kamenetsky M, Middelhaufe S, Bank E, Levin L, Buck J, Steegborn C. Molecular details of cAMP generation in mammalian cells: a tale of two systems. J Mol Biol 2006;362:623-39. (Pubitemid 44332423)
42. Srinivasan M, Aalinkeel R, Song F, Lee B, Laychock S, Patel M. Adaptive changes in insulin secretion by islets from neonatal rats raised on a high-carbohydrate formula. Am J Physiol Endocrinol Metab 2000;279:E1347-57.
43. Leech C, Castonguay M, Habener J. Expression of adenylyl cyclase subtypes in pancreatic beta-cells. Biochem Biophys Res Commun 1999;254:703-6. (Pubitemid 29290532)
44. Guenifi A, Portela-Gomes G, Grimelius L, Efendić S, Abdel-Halim S. Adenylyl cyclase isoform expression in non-diabetic and diabetic Goto-Kakizaki (GK) rat pancreas. Evidence for distinct overexpression of type-8 adenylyl cyclase in diabetic GK rat islets. Histochem Cell Biol 2000;113:81-9. (Pubitemid 30164413)
45. Delmeire D, Flamez D, Hinke S, Cali J, Pipeleers D, Schuit F. Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1. Diabetologia 2003;46:1383-93. (Pubitemid 37297209)
46. Seamon K, Daly J. Forskolin: its biological and chemical properties. Adv Cyclic Nucleotide Protein Phosphorylation Res 1986;20:1-150.
47. Insel P, Ostrom R. Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling. Cell Mol Neurobiol 2003;23:305-14. (Pubitemid 36676277)
48. Cali J, Zwaagstra J, Mons N, Cooper D, Krupinski J. Type VIII adenylyl cyclase. A Ca2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain. J Biol Chem 1994;269:12190-5.
49. Dolz M, Bailbé D, GiroixM, Calderari S, GangnerauM, Serradas P, Rickenbach K, Irminger J, Portha B. Restitution of defective glucose-stimulated insulin secretion in diabetic GK rat by acetylcholine uncovers paradoxical stimulatory effect of beta-cell muscarinic receptor activation on cAMP production. Diabetes 2005;54:3229-37. (Pubitemid 43334379)
50. Perry M, Higgs G. Chemotherapeutic potential of phosphodiesterase inhibitors. Curr Opin Chem Biol 1998;2:472-81. (Pubitemid 128645700)
51. Soderling S, Beavo J. Regulation of cAMP and cGMP signaling. new phosphodiesterases and new functions. Curr Opin Cell Biol 2000;12:174-9. (Pubitemid 30142563)
52. Mehats C, Andersen C, Filopanti M, Jin S, Conti M. Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling. Trends Endocrinol Metab 2002;13:29-35. (Pubitemid 36734013)
53. Conti M, Beavo J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 2007;76:481-511.
54. Pyne N, Furman B. Cyclic nucleotide phosphodiesterases in pancreatic islets. Diabetologia 2003;46:1179-89. (Pubitemid 37214975)
55. Furman B, Pyne N, Flatt P, O'Harte F. Targeting beta-cell cyclic 3'5' adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review. J Pharm Pharmacol 2004;56:1477-92. (Pubitemid 39610499)
56. 2+, calmodulin and trifluoperazine. Biochem J 1981;197:459-64. (Pubitemid 11013977)
57. Capito K, Hedeskov C, Thams P. Cyclic AMP phosphodiesterase activity in mouse pancreatic islets. Effects of calmodulin and phospholipids. Acta Endocrinol (Copenh) 1986;111:533-38. (Pubitemid 16086321)
58. Lipson L, Oldham S. The role of calmodulin in insulin secretion: the presence of a calmodulin-stimulatable phosphodiesterase in pancreatic islets of normal and pregnant rats. Life Sci 1983;32:775-80. (Pubitemid 13181117)
59. Han P, Werber J, Surana M, Fleischer N, Michaeli T. The calcium/calmodulin-dependent phosphodiesterase PDE1C down-regulates glucose-induced insulin secretion. J Biol Chem 1999;274:22337-44.
60. Ahmad M, Flatt P, Furman B, Pyne N. The role of the cyclic GMP-inhibited cyclic AMPspecific phosphodiesterase (PDE3) in regulating clonal BRIN-BD11 insulin secreting cell survival. Cell Signal 2000;12:541-48.
61. Shafiee-Nick R, Pyne N, Furman B. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity. Br J Pharmacol 1995;115:1486-92.
62. Parker J, VanVolkenburg M, Ketchum R, Brayman K, Andrews K. Cyclic AMP phosphodiesterases of human and rat islets of Langerhans: contributions of types III and IV to the modulation of insulin secretion. Biochem Biophys Res Commun 1995;217:916-23. (Pubitemid 26019742)
63. Zhao A, Zhao H, Teague J, Fujimoto W, Beavo J. Attenuation of insulin secretion by insulinlike growth factor 1 is mediated through activation of phosphodiesterase 3B. Proc Natl Acad Sci U S A 1997;94:3223-28. (Pubitemid 27157292)
64. Waddleton D, Wu W, Feng Y, Thompson C, Wu M, Zhou Y, Howard A, Thornberry N, Li J, Mancini J. Phosphodiesterase 3 and 4 comprise the major cAMP metabolizing enzymes responsible for insulin secretion in INS-1 (832/13) cells and rat islets. Biochem Pharmacol 2008;76:884-93.
65. Härndahl L, Jing X, Ivarsson R, Degerman E, Ahrén B, Manganiello V, Renström E, Holst L. Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta-cell exocytosis and release of insulin. J Biol Chem 2002;277:37446-55.
66. Härndahl L, Wierup N, Enerbäck S, Mulder H, Manganiello V, Sundler F, Degerman E, Ahrén B, Holst L. Beta-cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance, and deranged islet morphology. J Biol Chem 2004;279:15214-22. (Pubitemid 38618917)
67. Walz H, Härndahl L,Wierup N, Zmuda-Trzebiatowska E, Svennelid F, Manganiello V, Ploug T, Sundler F, Degerman E, Ahrén B, Holst L. Early and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B. J Endocrinol 2006;189:629-41.
68. Dov A, Abramovitch E,Warwar N, Nesher R. Diminished phosphodiesterase-8B potentiates biphasic insulin response to glucose. Endocrinology 2008;149:741-8. (Pubitemid 351159343)
69. Zhao A, Bornfeldt K, Beavo J. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. J Clin Invest 1998;102:869-73. (Pubitemid 28419231)
70. Grapengiesser E, Gylfe E, Dansk H, Hellman B. Nitric oxide induces synchronous Ca2+ transients in pancreatic beta cells lacking contact. Pancreas 2001;23:387-92. (Pubitemid 32983297)
71. Smukler S, Tang L, Wheeler M, Salapatek A. Exogenous nitric oxide and endogenous glucose-stimulated beta-cell nitric oxide augment insulin release. Diabetes 2002;51: 3450-60. (Pubitemid 35403449)
72. 2+ concentration and insulin secretion in rat pancreatic beta-cells. Am J Physiol Cell Physiol 2003;284:C1215-22. (Pubitemid 36457402)
73. + channels in rat pancreatic beta cells. Pflugers Arch 2008;456:573-9.
74. Cantin L, Magnuson S, Gunn D, Barucci N, Breuhaus M, BullockW, Burke J, Claus T, Daly M, Decarr L, Gore-Willse A, Hoover-Litty H, Kumarasinghe E, Li Y, Liang S, Livingston J, Lowinger T, Macdougall M, Ogutu H, Olague A, Ott-Morgan R, Schoenleber R, Tersteegen A,Wickens P, Zhang Z, Zhu J, Zhu L, Sweet L. PDE-10A inhibitors as insulin secretagogues. Bioorg Med Chem Lett 2007;17:2869-73. (Pubitemid 46636247)
75. Fridlyand LE, Harbeck MC, Roe MW, Philipson LH. Regulation of cAMP dynamics by Ca2+ and G protein-coupled receptors in the pancreatic β-cell. a computational approach. Am J Physiol Cell Physiol. 2007;293:C1924-33. (Pubitemid 350255070)
76. Dyachok O, Isakov Y, Sågetorp J, Tengholm A. Oscillations of cyclic AMP in hormonestimulated insulin-secreting beta-cells. Nature 2006;439:349-52. (Pubitemid 43128861)
77. Dyachok O, Sågetorp J, Isakov Y, Tengholm A. cAMP oscillations restrict protein kinase A redistribution in insulin-secreting cells. Biochem Soc Trans 2006;34:498-501. (Pubitemid 44230746)
78. Dyachok O, Idevall-Hagren O, Sågetorp J, Tian G,Wuttke A, Arrieumerlou C, Akusjärvi G, Gylfe E, Tengholm A. Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion. Cell Metab 2008;8:26-37. (Pubitemid 351859229)
79. 2+]i oscillations in mouse pancreatic islets by adrenergic agonists. Biochem Biophys Res Commun 2007;363:1038-43. (Pubitemid 47552961)
80. Jarnaess E, Taskén K. Spatiotemporal control of cAMP signalling processes by anchored signalling complexes. Biochem Soc Trans 2007;35:931-37. (Pubitemid 350206399)
81. Dodge-Kafka K, Kapiloff M. The mAKAP signaling complex: integration of cAMP, calcium, and MAP kinase signaling pathways. Eur J Cell Biol 2006;85:593-602. (Pubitemid 43863034)
82. Fraser I, Tavalin S, Lester L, Langeberg L, Westphal A, Dean R, Marrion N, Scott J. A novel lipid-anchored A-kinase Anchoring Protein facilitates cAMP-responsive membrane events. EMBO J 1998;17:2261-72. (Pubitemid 28171911)
83. Faruque O, Le-Nguyen D, Lajoix A, Vives E, Petit P, Bataille D, Hani e-H. Cell-permeable peptide-based disruption of endogenous PKA-AKAP complexes: a tool for studying the molecular roles of AKAP-mediated PKA subcellular anchoring. Am J Physiol Cell Physiol 2009;296:C306-16.
84. Jones PM, Persaud SJ. Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic β-cells. Endocr Rev. 1998;429-461. (Pubitemid 29116376)
85. Lester LB, Faux MC, Nauert JB, Scott JD. Targeted protein kinase A and PP-2B regulate insulin secretion through reversible phosphorylation. Endocrinology. 2001;142(3):1218-27. (Pubitemid 32202832)
86. Kopperud R, Krakstad C, Selheim F, Døskeland S. cAMP effector mechanisms. Novel twists for an 'old' signaling system. FEBS Lett 2003;546:121-6. (Pubitemid 36782292)
87. Renström E, Eliasson L, Rorsman P. Protein kinase A-dependent and independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells. J Physiol 1997;502:105-18. (Pubitemid 27322979)
88. Seino S, Shibasaki T. PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol Rev 2005;85:1303-42. (Pubitemid 41362272)
89. Shibasaki T, Takahashi H, Miki T, Sunaga Y, Matsumura K, Yamanaka M, Zhang C, Tamamoto A, Satoh T,Miyazaki J, Seino S. Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc Natl Acad Sci U S A; 2007;104:19333-193.
90. Holz G. Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptormediated signal transduction in the pancreatic beta-cell. Diabetes 2004;53:5-13. (Pubitemid 38044691)
91. Kashima Y, Miki T, Shibasaki T, Ozaki N, Miyazaki M, Yano H, Seino S. Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem 2001;276:46046-53.
92. Chepurny O, Leech C, Kelley G, Dzhura I, Dzhura E, Li X, Rindler M, Schwede F, Genieser H, Holz G. Enhanced Rap1 activation and insulin secretagogue properties of an acetoxymethyl ester of an Epac-selective cyclic AMP analog in rat INS-1 cells: Studies with 8-pCPT-2'-O-Me-cAMP-AM. J Biol Chem, 2009.
93. Liu G, Jacobo S, Hilliard N, Hockerman G. Differential modulation of Cav1.2 and Cav1.3- mediated glucose-stimulated insulin secretion by cAMP in INS-1 cells: distinct roles for exchange protein directly activated by cAMP 2 (Epac2) and protein kinase A. J Pharmacol Exp Ther 2006;318:152-60.
94. Nakazaki M, Crane A, Hu M, Seghers V, Ullrich S, Aguilar-Bryan L, Bryan J. cAMPactivated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets. Diabetes 2002;51:3440-9. (Pubitemid 35403448)
95. Eliasson L, Ma X, Renström E, Barg S, Berggren P, Galvanovskis J, Gromada J, Jing X, Lundquist I, Salehi A, Sewing S, Rorsman P. SUR1 regulates PKA-independent cAMPinduced granule priming in mouse pancreatic B-cells. J Gen Physiol 2003;121:181-97. (Pubitemid 36292989)
96. Malaisse W, Malaisse-Lagae F, Mayhew D. A possible role for the adenyl cyclase system in insulin secretion. J Clin Invest 1967;46:1724-34.
97. Brisson G, Malaisse-Lagae F, Malaisse W. The stimulus-secretion coupling of glucoseinduced insulin release. VII. A proposed site of action for adenosine-3',5'-cyclic monophosphate. J Clin Invest 1972;51:232-41.
98. Holz G, Kühtreiber W, Habener J. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 1993;361:362-5. (Pubitemid 23041630)
99. Gromada J, Bokvist K, Ding W, Holst J, Nielsen J, Rorsman P. Glucagon-like peptide 1 (7- 36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. Diabetes 1998;47:57-65. (Pubitemid 28030808)
100. 2+/ calmodulin-dependent pathway in mouse pancreatic β-cells. J Membr Biol 1998;166:237-44. (Pubitemid 28557792)
101. Light P, Manning Fox J, Riedel M, Wheeler M. Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism. Mol Endocrinol 2002;16:2135-44. (Pubitemid 35013461)
102. Kang G, Chepurny O, Malester B, Rindler M, Rehmann H, Bos J, Schwede F, Coetzee W, Holz G. cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic β cells and rat INS-1 cells. J Physiol 2006;573:595-609. (Pubitemid 43842505)
103. ATP channel ATP sensitivity in human pancreatic β-cells and rat INS-1 cells. J Physiol 2008;586:1307-19. (Pubitemid 351321270)
104. Kim S, Choi W, Han J, Warnock G, Fedida D, McIntosh C. A novel mechanism for the suppression of a voltage-gated potassium channel by glucose-dependent insulinotropic polypeptide: protein kinase A-dependent endocytosis. J Biol Chem 2005;280:28692-700. (Pubitemid 41105770)
105. MacDonald P, Salapatek A, Wheeler M. Glucagon-like peptide-1 receptor activation antagonizes voltage-dependent repolarizing K+ currents in β-cells: a possible glucose-dependent insulinotropic mechanism. Diabetes 51 Suppl 2002;3:S443-47. (Pubitemid 35403428)
106. + currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways. J Biol Chem 2003;278:52446-53. (Pubitemid 38035837)
107. Ammälä C, Ashcroft F, Rorsman P. Calcium-independent potentiation of insulin release by cyclic AMP in single beta-cells. Nature 1993;363:356-58. (Pubitemid 23161532)
108. 2+ channels in rat islet beta-cells. Pflugers Arch 1998;435:578-80. (Pubitemid 28075442)
109. 2+ channel of rat pancreatic β-cell in a cAMP-dependent manner. Diabetes 1997;46:1755-60. (Pubitemid 27456407)
110. 2+ channel in a murine pancreatic β-cell line. Diabetes 1996;45:1412-8. (Pubitemid 26332906)
111. Gromada J, Dissing S, Bokvist K, Renström E, Frøkjaer-Jensen J, Wulff B, Rorsman P. Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization. Diabetes 1995;44:767-74.
112. Islam M, Leibiger I, Leibiger B, Rossi D, Sorrentino V, Ekstrfm T, Westerblad H, Andrade F, Berggren P. In situ activation of the type 2 ryanodine receptor in pancreatic β cells requires cAMP-dependent phosphorylation. Proc Natl Acad Sci U S A 1998;95:6145-50. (Pubitemid 28248979)
113. 2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37). J Biol Chem 1999;274:14147-56.
114. 2+ release in INS-1 pancreatic β-cells. J Physiol 2001;536:375-85. (Pubitemid 32976119)
115. 2+ release and exocytosis in pancreatic β-cells. J Biol Chem 2003;278:8279-85. (Pubitemid 36800574)
116. 2+ release in mouse pancreatic β cells. J Physiol 2005;566:173-88. (Pubitemid 40984212)
117. Bode H, Moormann B, Dabew R, Göke B. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic beta-cells independently of protein kinase A. Endocrinology 1999;140:3919-27. (Pubitemid 30647085)
118. 2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 β-cells. Biochem J 2003;369:287-99. (Pubitemid 36174198)
119. 2+ release via inositol 1,4,5-trisphosphate receptors is amplified by protein kinase A and triggers exocytosis in pancreatic β-cells. J Biol Chem 2004;279:45455-61. (Pubitemid 39491530)
120. 2+ signal that is essential for insulin secretion in mouse pancreatic islets. Diabetes 2008;57:868-78.
121. Gillis K, Misler S. Enhancers of cytosolic cAMP augment depolarization-induced exocytosis from pancreatic B-cells: evidence for effects distal to Ca2+ entry. Pflugers Arch 1993;424:195-7. (Pubitemid 23200592)
122. Ding W, Gromada J. Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide. Diabetes 1997;46:615-21. (Pubitemid 27143377)
123. Hatakeyama H, Kishimoto T, Nemoto T, Kasai H, Takahashi N. Rapid glucose sensing by protein kinase A for insulin exocytosis in mouse pancreatic islets. J Physiol 2006;570: 271-82.
124. Hatakeyama H, Takahashi N, Kishimoto T, Nemoto T, Kasai H. Two cAMP-dependent pathways differentially regulate exocytosis of large dense-core and small vesicles in mouse β-cells. J Physiol 2007;582:1087-98. (Pubitemid 47104342)
125. 2+ and ATP in rat islet beta-cells. Diabetes Metab Res Rev 2006;22:64-71. (Pubitemid 43154464)
126. Kwan E, Gaisano H. Glucagon-like peptide 1 regulates sequential and compound exocytosis in pancreatic islet β-cells. Diabetes 2005;54:2734-43. (Pubitemid 41233597)
127. Kwan E, Xie L, Sheu L, Ohtsuka T, Gaisano H. Interaction between Munc13-1 and RIM is critical for glucagon-like peptide-1 mediated rescue of exocytotic defects in Munc13-1 deficient pancreatic beta-cells. Diabetes 2007;56:2579-88. (Pubitemid 47523266)
128. Kwan E, Gao X, Leung Y, Gaisano H. Activation of exchange protein directly activated by cyclic adenosine monophosphate and protein kinase A regulate common and distinct steps in promoting plasma membrane exocytic and granule-to-granule fusions in rat islet beta cells. Pancreas 2007;35:e45-54. (Pubitemid 47482535)
129. 2+-dependent activation of phospholipase C in insulin-secreting cells. J Biol Chem 2006;281:28499-507. (Pubitemid 44506992)
130. Chepurny O, Hussain M, Holz G. Exendin-4 as a stimulator of rat insulin I gene promoter activity via bZIP/CRE interactions sensitive to serine/threonine protein kinase inhibitor Ro 31-8220. Endocrinology 2002;143:2303-13. (Pubitemid 34521577)
131. Xie T, Chen M, Zhang Q, Ma Z,Weinstein L. β-cell-specific deficiency of the stimulatory G protein a-subunit Gsa leads to reduced β-cell mass and insulin-deficient diabetes. Proc Natl Acad Sci U S A. 2007;104:19601-6.
132. Elrick L, Docherty K. Phosphorylation-dependent nucleocytoplasmic shuttling of pancreatic duodenal homeobox-1. Diabetes 2001;50:2244-52. (Pubitemid 33641908)
133. Wang X, Zhou J, Doyle M, Egan J. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic β-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism. Endocrinology 2001;142:1820-27. (Pubitemid 32405938)
134. Song W, Schreiber W, Zhong E, Liu F, Kornfeld B, Wondisford F, Hussain M. Exendin-4 stimulation of cyclin A2 in β-cell proliferation. Diabetes 2008;57:2371-81.
135. Kim S, Nian C, Widenmaier S, McIntosh C. Glucose-dependent insulinotropic polypeptidemediated up-regulation of beta-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2. Mol Cell Biol 2008;28:1644-56.
136. Jansson D, Ng A, Fu A, Depatie C, Al Azzabi M, Screaton R. Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proc Natl Acad Sci U S A 2008;105:10161-66.
137. Jonas J, Laybutt D, Steil G, Trivedi N, Pertusa J, Van de Casteele M, Weir G, Henquin J. High glucose stimulates early response gene c-Myc expression in rat pancreatic beta cells. J Biol Chem 2001;276:35375-81.
138. Susini S, Roche E, Prentki M, Schlegel W. Glucose and glucoincretin peptides synergize to induce c-fos, c-jun, junB, zif-268, and nur-77 gene expression in pancreatic beta(INS-1) cells. FASEB J 1998;12:1173-82. (Pubitemid 28418947)
139. Glauser D, Brun T, Gauthier B, Schlegel W. Transcriptional response of pancreatic beta cells to metabolic stimulation: large scale identification of immediate-early and secondary response genes. BMC Mol Biol 2007;8:54.
140. Frödin M, Sekine N, Roche E, Filloux C, Prentki M, Wollheim C, Van Obberghen E. Glucose, other secretagogues, and nerve growth factor stimulate mitogen-activated protein kinase in the insulin-secreting beta-cell line, INS-1. J Biol Chem 1995;270:7882-89.
141. Benes C, Roisin M, Van Tan H, Creuzet C, Miyazaki J, Fagard R. Rapid activation and nuclear translocation of mitogen-activated protein kinases in response to physiological concentration of glucose in the MIN6 pancreatic beta cell line. J Biol Chem 1998;273:15507-13. (Pubitemid 28298160)
142. Benes C, Poitout V, Marie J, Martin-Perez J, Roisin M, Fagard R. Mode of regulation of the extracellular signal-regulated kinases in the pancreatic beta-cell line MIN6 and their implication in the regulation of insulin gene transcription. Biochem J 1999;340 (Pt 1): 219-25. (Pubitemid 29251110)
143. 2+ influx through L-type voltage-gated calcium channels mediate Raf-independent activation of extracellular regulated kinase in response to glucagon-like peptide-1 in pancreatic β-cells. J Biol Chem 2002;277:48146-51. (Pubitemid 35470763)
144. Ehses J, Pelech S, Pederson R, McIntosh C. Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway. J Biol Chem 2002;277:37088-97.
145. Drucker D. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 2003;17:161-71. (Pubitemid 36183142)
146. Hui H, Nourparvar A, Zhao X, Perfetti R. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase Aand a phosphatidylinositol 3-kinase-dependent pathway. Endocrinology 2003;144:1444-55. (Pubitemid 36432086)
147. Ehses J, Casilla V, Doty T, Pospisilik J, Winter K, Demuth H, Pederson R, McIntosh C. Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogenactivated protein kinase. Endocrinology 2003;144:4433-45. (Pubitemid 37204843)
148. Ranta F, Avram D, Berchtold S, Düfer M, Drews G, Lang F, Ullrich S. Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4. Diabetes 2006;55:1380-90. (Pubitemid 44195377)
149. Granata R, Settanni F, Biancone L, Trovato L, Nano R, Bertuzzi F, Destefanis S, Annunziata M, Martinetti M, Catapano F, Ghè C, Isgaard J, Papotti M, Ghigo E, Muccioli G. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. Endocrinology 2007;148:512-29. (Pubitemid 46143157)
150. Granata R, Settanni F, Gallo D, Trovato L, Biancone L, Cantaluppi V, Nano R, Annunziata M, Campiglia P, Arnoletti E, Ghè C, Volante M, Papotti M, Muccioli G, Ghigo E. Obestatin promotes survival of pancreatic β-cells and human islets and induces expression of genes involved in the regulation of β-cell mass and function. Diabetes 2008;57:967-79.
151. Ferdaoussi M, Abdelli S, Yang J, Cornu M, Niederhauser G, Favre D, Widmann C, Regazzi R, Thorens B, Waeber G, Abderrahmani A. Exendin-4 protects β-cells from interleukin-1 beta-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway. Diabetes 2008;57:1205-15.
152. Loweth A, Williams G, Scarpello J, Morgan N. Heterotrimeric G-proteins are implicated in the regulation of apoptosis in pancreatic β-cells. Exp Cell Res 1996;229:69-76. (Pubitemid 26423935)
153. Ahmad M, Abdel-Wahab YH, Tate R, Flatt PR, Pyne NJ, Furman BL. Effect of typeselective inhibitors on cyclic nucleotide phosphodiesterase activity and insulin secretion in the clonal insulin secreting cell line BRIN-BD11. Br J Pharmacol. 2000;129:1228-34. (Pubitemid 30153980)
154. Andersen H, Mauricio D, Karlsen A, Mandrup-Poulsen T, Nielsen J, Nerup J. Interleukin-1 β-induced nitric oxide production from isolated rat islets is modulated by D-glucose and 3-isobutyl-1-methyl xanthine. Eur J Endocrinol 1996;134:251-9.
155. Friedrichsen B, Neubauer N, Lee Y, Gram V, Blume N, Petersen J, Nielsen J, M?ldrup A. Stimulation of pancreatic β-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J Endocrinol 2006;188:481-92.
156. Klinger S, Poussin C, Debril M, Dolci W, Halban P, Thorens B. Increasing GLP-1-induced β-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14. Diabetes 2008;57:584-93.
157. Kim M, Kang J, Park Y, Ryu G, Ko S, Jeong I, Koh K, Rhie D, Yoon S, Hahn S, Kim M, Jo Y. Exendin-4 induction of cyclin D1 expression in INS-1 β-cells: involvement of cAMP-responsive element. J Endocrinol 2006;188:623-33.
158. Welters H, Kulkarni R. Wnt signaling: relevance to β-cell biology and diabetes. Trends Endocrinol Metab. 2008;349-55.
159. Liu Z, Habener J. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic β cell proliferation. J Biol Chem 2008;283:8723-35.
160. Hii C, Howell S. Role of second messengers in the regulation of glucagon secretion from isolated rat islets of Langerhans. Mol Cell Endocrinol 1987;50:37-44. (Pubitemid 17039230)
161. 2+-induced secretion in rat a-cells by a protein kinase A-mediated mechanism. Diabetes 1997;46:792-800. (Pubitemid 27188256)
162. Dillon J, Lu M, Bowen S, Homan L. The recombinant rat glucagon-like peptide-1 receptor, expressed in an a-cell line, is coupled to adenylyl cyclase activation and intracellular calcium release. Exp Clin Endocrinol Diabetes 2005;113:182-9. (Pubitemid 40516361)
163. Islam D, Zhang N, Wang P, Li H, Brubaker P, Gaisano H, Wang Q, Jin T. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic a- and intestinal L-cell lines. Am J Physiol Endocrinol Metab 2009;296:E174-81.
164. Dunning B, Foley J, Ahrén B. Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia 2005;48:1700-13. (Pubitemid 41317822)
165. Gromada J, Hy M, Buschard K, Salehi A, Rorsman P. Somatostatin inhibits exocytosis in rat pancreatic a-cells by G(i2)-dependent activation of calcineurin and depriming of secretory granules. J Physiol 2001;535:519-32. (Pubitemid 32825687)
166. Gros L, Thorens B, Bataille D, Kervran A. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line. Endocrinology. 1993;133:631-8. (Pubitemid 23238873)
167. Fehmann H, Janssen M, Göke B. Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells. Acta Diabetol 1995;32:176-81.
168. Patel Y, Papachristou D, Zingg H, Farkas E. Regulation of islet somatostatin secretion and gene expression: selective effects of adenosine 3',5'-monophosphate and phorbol esters in normal islets of Langerhans and in a somatostatin-producing rat islet clonal cell line 1027 B2. Endocrinology 1991;128:1754-62.
169. Ma X, Zhang Y, Gromada J, Sewing S, Berggren P, Buschard K, Salehi A, Vikman J, Rorsman P, Eliasson L. Glucagon stimulates exocytosis in mouse and rat pancreatic a-cells by binding to glucagon receptors. Mol Endocrinol 2005;19:198-12. (Pubitemid 40065970)
170. 2+ channels. J Gen Physiol 1997;110:217-28. (Pubitemid 27388115)
171. Vieira E, Liu Y, Gylfe E. Involvement of alpha1 and beta-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell. Naunyn Schmiedebergs Arch Pharmacol 2004;369:179-83. (Pubitemid 38270773)
172. Knudsen L, Kiel D, Teng M, Behrens C, Bhumralkar D, Kodra J, Holst J, Jeppesen C, Johnson M, de Jong J, Jorgensen A, Kercher T, Kostrowicki J, Madsen P, Olesen P, Petersen J, Poulsen F, Sidelmann U, Sturis J, Truesdale L, May J, Lau J. Small-molecule agonists for the glucagon-like peptide 1 receptor. Proc Natl Acad Sci U S A 104: 2007;937-42. (Pubitemid 46154715)